Autoimmune progesterone dermatitis presented as acute generalized exanthematous pustulosis
DOI:
https://doi.org/10.66344/jpad.v28i1.989Keywords:
Autoimmune progesterone dermatitis, cyclical, acute generalized exanthematous pustulosisAbstract
Autoimmune progesterone dermatitis (AIPD) is a rare autoimmune response to endogenous progesterone, characterized by cyclic cutaneous and mucosal lesions at the end of the luteal phase with varied type of skin lesions include urticaria, angioedema, erythema multiforme, eczema, folliculitis, papulovesicular eruptions, fixed drug eruption, purpura, or vulvovaginal pruritus and anaphylaxis. We report a case of AIPD presenting as acute generalized exanthematous pustulosis (AGEP). She had papulovesicular lesions with sheet of pustules that appeared in relation with menstrual cycle. Progesterone intradermal test was positive. She was treated successfully with combination oral pills.
References
1. Millington GWM, Graham-Brown RAC. Skin and skin disease throughout life. In: DA Burns, SM Breathnach, NH Cox, CEM Griffins, editors. Rook's Textbook of Dermatology, 8th edition. New York: Wile-Blackwell; 2010. p 8.8.
2. Lee MK, Lee WY, Yong SJ, Shin KC, Lee SN, Lee SJ et al. A case of autoimmune progesterone dermatitis misdiagnosed as allergic contact dermatitis. Allergy Asthma Immunol Res. 2011;3:141-44.
3. Prieto-Garcia A, Sloane DE, Gargiulo AR, Feldweg AM, Castells M. Autoimmune progesterone dermatitis: clinical presentation and management with progesterone desensitization for successful in vitro fertilization. Fertil Steril. 2011;95:1121.
4. Sidoroff A, Halevy S, Bavinck JN, Vaillant L, Roujeau JC. Acute generalized exanthematous pustulosis(AGEP) –A clinical reaction pattern. J Cutan Pathol. 2001;28:113-9.
5. Baptist AP, Baldwin JL. Autoimmune progesterone dermatitis in a patient with endometriosis: case report and review of the literature. Clin Mol Allergy. 2004;2:10.
6. Snyder JL, Krishnaswamy G. Autoimmune progesterone dermatitis and its manifestation as anaphylaxis: a case report and literature review. Ann Allergy Asthma Immunol. 2003;90:469-76.
7. Wintzen M, Goor-van Egmond MBT, Noz KC. Autoimmune progesterone dermatitis presenting with purpura and petechiae. Clin Exp Dermatol. 2003;29:311-24.
8. Walling HW, Scupham RK. Autoimmune progesterone dermatitis. Case report with histologic overlap of erythema multiforme and urticarial. Int J Dermatol. 2008;47:380-2.
9. Rasi A, Khatami A. Autoimmune progesterone dermatitis. Int J Dermatol. 2004;43:588-90.
10. Farah FS, Shbaklu Z: Autoimmune progesterone urticaria. 1971;48:257-61.
11. Bumbacea RS, Ghiordanescu IM, Tudose I, Popa LG, Badiu C, Giurcaneanu C. Autoimmune progesterone dermatitis in a patient with no medical history of hormonal contraception or pregnancy. Acta Endocrinol (Buc). 2015;XI:99-102.
12. Schoenmakers A, Vermorken A, Degreef H, Dooms-Goossens A. Corticosteroid or steroid allergy? Contact Dermatitis. 1992;26:159-62.
13. Dosiou C, Hamilton AE, Y Pang Y, Overgaard MT, Tulac S, Dong J et al. Expression of membrane progesterone receptors on human T lymphocytes and Jurkat cells and activation of G-proteins by progesterone. J Endocrinol. 2008;196:67-77.
14. Warin AP. Case 2, Diagnosis: erythema multiforme as a presentation of autoimmune progesterone dermatitis. Clin Exp Dermatol. 2001;26.107-8.
15. Shelley WB, Preucel RW, Spoont SS. Autoimmune progesterone dermatitis. Cure by oophorectomy. JAMA. 1964;190:35-8.
16. Fournier JB. Resolution of autoimmune progesterone dermatitis after treatment with oral contraceptives. J Am Acad Dermatol. 2015;1:319-20.
Downloads
Published
Issue
Section
License
Copyright (c) 2018 Suchibrata Das, Sangita Patra, Saikat Banerjee, Saswati Das
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
